Aptamer-engineered extended-gate field-effect transistor device for point-of-care therapeutic drug monitoring.
Analyst
; 147(20): 4413-4416, 2022 Oct 10.
Article
en En
| MEDLINE
| ID: mdl-36148514
Herein, we report a portable point-of-care testing (POCT) device based on an aptamer-engineered extended-gate field-effect transistor (EG-FET) for therapeutic monitoring of the drug methotrexate. This method was shown to be highly sensitive, efficient, and convenient to use, features contributing to its realizing a clinical detection of drugs in blood.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Técnicas Biosensibles
Idioma:
En
Año:
2022
Tipo del documento:
Article